-

$7 Million Investment Fuels Health Tech Innovation in Arizona

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Xcellerant Ventures (XVC) is proud to announce a strategic partnership with AZ Venture Capital Inc. (AVC), bringing $7 million in new funding to Arizona-based health technology startups. The $7 million, total, that is available for Arizona startups was made possible by a $5 million investment by AVC into XVC’s Fund. According to Douglas Sylvester, a general partner in XVC, “The $5 million from AZ Venture Capital spurred our investors to add $2 million to our Fund. This additional funding strengthens the state’s growing position as a hub for healthcare innovation, empowering entrepreneurs to develop transformative solutions that improve patient care, accessibility, and affordability.”

AVC plays a critical role in Arizona’s economic development by investing in top-tier venture funds that drive local innovation. By investing in XVC’s Fund I, AVC is propelling the growth of high-potential healthcare startups—giving them the resources to develop groundbreaking technologies that will transform patient care and the future of medicine. The fund focuses on early-stage companies led by dynamic founders with strong intellectual property and a clear vision for improving health outcomes.

XVC’s portfolio already includes ten cutting-edge healthcare companies, with half of them having a headquarters or significant presence in Arizona. This latest investment will expand that impact, ensuring even more homegrown entrepreneurs have the resources, capital, and mentorship needed to scale their innovations within the state.

“Arizona’s innovation economy is thriving, and health technology is at the forefront of that growth,” said James Goulka, President & CEO of AZ Venture Capital Inc. “By investing in Xcellerant Ventures, we are ensuring that Arizona’s most promising healthcare entrepreneurs have the capital and support they need to scale groundbreaking solutions. This partnership reflects our commitment to transforming Arizona into a national leader in health tech.”

As Arizona cements itself as a leader in health technology, investments like this drive economic growth, job creation, and groundbreaking advancements in patient care. With AVC’s strategic support and XVC’s expertise in scaling early-stage startups, Arizona is poised to become a national powerhouse for health tech innovation.

About Xcellerant Ventures

Xcellerant Ventures is an early-stage venture firm investing in transformative healthcare companies. With a focus on innovation, accessibility, and impact, XVC partners with visionary founders to accelerate breakthroughs that redefine the future of healthcare.

About AZ Venture Capital Inc.

Arizona Venture Capital Inc. is dedicated to fostering a robust entrepreneurial ecosystem by investing in venture capital funds that support Arizona’s most promising startups. Through strategic capital deployment, AVC helps drive innovation, economic development, and long-term business success in the state.

Contacts

Xcellerant Ventures
Tiffany Panessa Youtchoko
tyoutchoko@xcellerantventures.com

AZ Venture Capital Inc.
info@azventurecap.com

More News From Xcellerant Ventures

Xcellerant Ventures Invests in Mindset Medical to Advance Contactless Vital Sign Monitoring

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Xcellerant Ventures (XVC) is proud to announce its investment in Mindset Medical (Mindset), a Phoenix-based digital health company pioneering software-only, contactless vital sign monitoring. This investment marks the latest addition to Xcellerant VC Fund 1, underscoring the fund's commitment to backing transformative healthcare technologies. John Shufeldt, Managing Partner at XVC, will join the board. Mindset's proprietary remote photoplethysmography (rPPG)...

Xcellerant Ventures Leads DeepLook Medical’s Series A Round

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Xcellerant Ventures is proud to announce that it will lead DeepLook Medical’s Series A funding round. DeepLook Medical, a healthtech company specializing in visual enhancement technology for advanced medical imaging, marks the 11th investment in Xcellerant VC Fund 1. Michael Shufeldt, MBA, Principal at Xcellerant Ventures, will join the board. DeepLook Medical's flagship product, DL Precise™, is an innovative AI-powered software that equips healthcare profess...

Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Xcellerant Ventures is proud to announce its investment in CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first platform to precisely analyze the quality of the CRISPR/CAS9 gene editing system. By providing a way to standardize measurements for efficiency and accuracy, CRISPR QC enables pharmaceutical and agriculture companies to quickly screen for the best therapeutics to develop into next generation personalized medicine...
Back to Newsroom